Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Post-sepsis chronic muscle weakness can be prevented by pharmacological protection of mitochondria

Molecular Medicine(2024)10.1186/s10020-024-00982-wSource: DataRank Database

Post-sepsis chronic muscle weakness can be prevented by pharmacological protection of mitochondria is a research paper published in Molecular Medicine (2024). On theSindex it has a DataRank of 0. It has been cited 19 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access19 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 5.88)OA: goldTopics (51)Linked Datasets (2)DataCite Reuse (2)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Alexander R. Keeble ORCID,Alyson M. Galvan-Lara,Jodi M. Ogle,Zoltán Ungvári ORCID,Daret K. St. Clair

Live enrichment

PubMed:39563237 PMC:PMC11577827 OpenAlex:https://openalex.org/W4404514625

National Institute of Health

Grant: R01 GM126181

National Institutes of Health

Grant: 5R01GM126181-02

Chronic muscle weakness in sepsis survivors

FWCI

5.88

Citation Percentile

1.0%

Citation Trend

2025

2026

goldLicense: cc-by

journalhttps://molmed.biomedcentral.com/counter/pdf/10.1186/s10020-024-00982-w

publisherhttps://molmed.biomedcentral.com/counter/pdf/10.1186/s10020-024-00982-w

publisherhttps://link.springer.com/content/pdf/10.1186/s10020-024-00982-w.pdf

publisherhttps://link.springer.com/article/10.1186/s10020-024-00982-w/fulltext.html

journalhttps://doi.org/10.1186/s10020-024-00982-w

Fields of Study

Intensive Care Unit Cognitive DisordersMuscle Physiology and DisordersMitochondrial Function and Pathology0301 basic medicine03 medical and health sciences0303 health sciences

MeSH Terms

AnimalsDisease Models, AnimalFemaleMaleMice, Inbred C57BLMice, TransgenicMitochondriaMitochondria, MuscleOligopeptidesSuperoxide DismutaseMuscle, SkeletalSepsisMuscle WeaknessMice

Keywords

SepsisSkeletal muscleMuscle weaknessWeaknessMedicineMitochondrionInternal medicinePathologyBiologyImmunologySurgeryBiochemistryMitochondrial MyopathyCritical Care IllnessPost-sepsis syndromeMaleMice, TransgenicRM1-950QD415-436MiceAnimalsMuscle, SkeletalSuperoxide DismutaseResearchMitochondriaMitochondria, MuscleMice, Inbred C57BLDisease Models, AnimalFemaleTherapeutics. PharmacologyOligopeptides

Sustainable Development Goals

SDG 0: Good health and well-being

Additional file 1 of Post-sepsis chronic muscle weakness can be prevented by pharmacological protection of mitochondria

10.6084/m9.figshare.27861329.v1figshare

Additional file 1 of Post-sepsis chronic muscle weakness can be prevented by pharmacological protection of mitochondria

10.6084/m9.figshare.27861329figshare

Post-sepsis chronic muscle weakness can be prevented by pharmacological protection of mitochondria

FAIR Checklist

Authors (11)

Funding (2 grants)

Impact

Open Access

Topics

Linked Datasets (2)

Annotations (Europe PMC)